# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001029142-25-000049
Filing Date
2025-02-20
Accepted
2025-02-20 16:15:31
Documents
116
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | dvax-20241231.htm iXBRL | 10-K | 2345735
2 | EX-4.1 | exhibit41-descriptionofcap.htm | EX-4.1 | 44146
3 | EX-10.5 | exhibit105-offerletterxjoh.htm | EX-10.5 | 21177
4 | EX-10.7 | exhibit107_amendment1peter.htm | EX-10.7 | 13375
5 | EX-10.11 | exhibit1011_directorcompen.htm | EX-10.11 | 23194
6 | EX-10.24 | exhibit1024_onyxdusseldorf.htm | EX-10.24 | 46052
7 | EX-10.26 | exhibit1026-firstamendment.htm | EX-10.26 | 57120
8 | EX-10.29 | exhibit1029_secondamendmen.htm | EX-10.29 | 117482
9 | EX-10.30 | exhibit1030_westsupplyagre.htm | EX-10.30 | 120912
10 | EX-19.1 | exhibit191_insidertradingp.htm | EX-19.1 | 101973
11 | EX-21.1 | exhibit211-listofsubsidiar.htm | EX-21.1 | 1409
12 | EX-23.1 | exhibit231-eyconsent.htm | EX-23.1 | 4022
13 | EX-31.1 | dvax-20241231xex3111.htm | EX-31.1 | 10228
14 | EX-31.2 | dvax-20241231xex3121.htm | EX-31.2 | 10216
15 | EX-32.1 | dvax-20241231xex3211.htm | EX-32.1 | 5642
16 | EX-32.2 | dvax-20241231xex3221.htm | EX-32.2 | 5645
22 |  | dvax-20241231_g1.jpg | GRAPHIC | 131521
23 |  | image_0a.jpg | GRAPHIC | 6220
24 |  | image_1a.jpg | GRAPHIC | 5638
25 |  | image_2a.jpg | GRAPHIC | 121
| Complete submission text file | 0001029142-25-000049.txt |  | 12579682

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
17 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | dvax-20241231.xsd | EX-101.SCH | 85607
18 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | dvax-20241231_cal.xml | EX-101.CAL | 123058
19 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | dvax-20241231_def.xml | EX-101.DEF | 354513
20 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | dvax-20241231_lab.xml | EX-101.LAB | 992216
21 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | dvax-20241231_pre.xml | EX-101.PRE | 668139
119 | EXTRACTED XBRL INSTANCE DOCUMENT | dvax-20241231_htm.xml | XML | 1653165

Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34207 | Film No.: 25645586
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)